Thermo Fisher Scientific | TMO - Bruttoergebnis Vom Umsatz

Aktienkurs
466.46
Täglich Wechseln
-3.76 -0.80%
Monatlich
-2.83%
Jährlich
8.73%
Q2 Prognose
459.66




Bruttoergebnis Vom Umsatz Veränderung Datum
Abbott USD 5.86B 675M 2026-03
Agilent USD 946M 44M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Bio Techne USD 191.28M 3.16M 2025-12
Bio-Rad Laboratories USD 343.4M 1.9M 2025-09
Boston Scientific USD 3.61B 64M 2026-03
Bruker USD 449.2M 69.8M 2025-12
Charles River Laboratories USD 271.96M 39.43M 2025-12
Danaher USD 3.59B 375M 2026-03
Dentsply International USD 443M 2M 2025-12
Edwards Lifesciences USD 1.29B 59.4M 2026-03
General Electric Aerospace USD 4.24B 439M 2026-03
Henry Schein USD 1.06B 37M 2025-12
Illumina USD 759M 26M 2025-12
Intuitive Surgical USD 1.83B 73.8M 2026-03
IQVIA Holdings USD 1.12B 32M 2025-12
Laboratory Of America USD 993.2M 31.9M 2025-12
Medtronic USD 5.41B 27M 2025-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
Olympus JPY 164.9B 3.6B 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Repligen USD 103.83M 3.32M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Stryker USD 4.49B 633M 2025-12
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Veracyte USD 101.97M 10.69M 2025-12
Waters USD 557.42M 97.44M 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12